Chemoinformaics analysis of bisbenzylisoquinoline
| Molecular Weight | 309.412 | nRot | 4 |
| Heavy Atom Molecular Weight | 290.26 | nRig | 23 |
| Exact Molecular Weight | 309.152 | nRing | 4 |
| Solubility: LogS | -6.401 | nHRing | 1 |
| Solubility: LogP | 5.558 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 4 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 3 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 19 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 23 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 22 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 23 |
| nHA | 1 | APOL | 52.1791 |
| nHD | 0 | BPOL | 20.2009 |
| QED | 0.491 |
| Synth | 1.89 |
| Natural Product Likeliness | -0.268 |
| NR-PPAR-gamma | 0.717 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.903 |
| Pgp-sub | 0.669 |
| HIA | 0.007 |
| CACO-2 | -4.916 |
| MDCK | 0.0000282 |
| BBB | 0.495 |
| PPB | 0.994258 |
| VDSS | 0.898 |
| FU | 0.0109539 |
| CYP1A2-inh | 0.349 |
| CYP1A2-sub | 0.375 |
| CYP2c19-inh | 0.856 |
| CYP2c19-sub | 0.065 |
| CYP2c9-inh | 0.685 |
| CYP2c9-sub | 0.119 |
| CYP2d6-inh | 0.132 |
| CYP2d6-sub | 0.129 |
| CYP3a4-inh | 0.699 |
| CYP3a4-sub | 0.886 |
| CL | 8.798 |
| T12 | 0.345 |
| hERG | 0.39 |
| Ames | 0.735 |
| ROA | 0.02 |
| SkinSen | 0.609 |
| Carcinogencity | 0.689 |
| EI | 0.301 |
| Respiratory | 0.711 |
| NR-Aromatase | 0.02 |
| Antiviral | No |
| Prediction | 0.602236 |